Matthias Zilbauer

University of Cambridge
Country flagUnited Kingdom

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (9)

Motivation Long COVID is a multisystem condition characterized by persistent symptoms such as fatigue, cognitive impairment, and systemic inflammation, following COVID-19 infection. However, its mechanisms remain poorly understood. In this study, we applied the quantum walk, a computational approach leveraging quantum interference, to explore large-scale SARS-CoV-2–induced protein networks. Result Compared to the conventional random walk with restart method, the quantum walk demonstrated superior capacity to traverse deeper regions of the network, uncovering proteins and pathways implicated in Long COVID. Key findings include mitochondrial dysfunction, thromboinflammatory responses, and neuronal inflammation as central mechanisms. Quantum walk uniquely identified the CDGSH iron-sulfur domain-containing protein family and VDAC1, a mitochondrial calcium transporter, as critical regulators of these processes. VDAC1 emerged as a potential biomarker and therapeutic target, supported by FDA-approved compounds such as cannabidiol. These findings highlight quantum walk as a powerful tool for elucidating complex biological systems and identifying novel therapeutic targets for conditions like Long COVID. Availability and implementation The code and input data that were used for this study are available at https://github.com/Namshik-Han-Lab/QuantumWalk-LongCovid.

Year:

2026

Bats can host viruses of pandemic concern without developing disease. The mechanisms underlying their exceptional resilience to viral infections are largely unresolved, necessitating the development of physiologically relevant and genetically tractable research models. Here, we developed respiratory and intestinal organoids that recapitulated the cellular diversity of the in vivo epithelium present in Rousettus aegyptiacus , the natural reservoir for the highly pathogenic Marburg virus (MARV). In contrast to human counterparts, bat organoids and mucosal tissue exhibited elevated constitutive expression of innate immune effectors, including type I interferon-ε (IFNε) and IFN-stimulated genes (ISGs). Upon infection with diverse zoonotic viruses, including MARV, bat organoids strongly induced type I and III IFN responses, which conferred robust antiviral protection. Type III IFNλ3 additionally displayed virus-independent self-amplification, acting as an ISG to enhance antiviral immunity. Our organoid platform reveals key features of bat epithelial antiviral immunity that may inform therapeutic strategies for viral disease resilience.

Year:

2025

2D characterization of organoids by light microscopy with live cell imaging systems provides a powerful, rapid approach toward characterizing organoid growth patterns and behavior under different conditions with high temporal resolution. However, current conventional analysis methods display critical flaws in their approximations, including inaccurate assumptions of linear light absorption kinetics and inappropriate normalization of organoid darkness. Organoid darkness represents cellular shedding and debris accumulation in the lumen of organoids and is thus proportional to the surface area, rather than to a 2D organoid projection as is conventionally used. This novel model and image processing pipeline accounts for these shortcomings by incorporating logarithmic light absorption parameters, a noncumulative measure of darkness, and surface area‐normalized darkness values which yield accurate and highly reproducible representation of organoid growth kinetics.

Year:

2025

Human milk oligosaccharides (HMOs) are a major component of human breast milk and have significant protective effects on infant gut health. HMOs are also present in the amniotic fluid surrounding the developing fetus in the womb. Beginning at 10 weeks of gestational age, HMOs enter the fetal gut through the swallowing of amniotic fluid. The effects of this earliest exposure to HMOs on the gut epithelium, which pre-term infants partially miss, remains unknown. In this study, we investigate the effect of a blend of HMOs, including 2’-fucosyllactose (2’FL), 3’-sialyllactose (3’SL), and difucosyllactose (DFL), on intestinal epithelial cells, examining their role in steady-state conditions and during inflammation. By utilizing advanced intestinal epithelial organoid models derived from fetal and pediatric donors, we reveal developmental-stage-specific responses to this HMO blend, as well as its potential to mitigate inflammatory damage. These findings offer important insights into the role of HMOs in early-life nutrition and gut health, lending compelling evidence to support their inclusion in infant nutrition strategies.

Year:

2025

The gastrointestinal (GI) tract consists of connected organs, from the oral cavity to rectum, which function to ensure efficient nutrient uptake and barrier immunity. Diseases of the GI tract affect millions worldwide and as such there are now over 25 published single cell RNA-sequencing (scRNAseq) datasets surveying the GI tract, profiling specific anatomical regions, cell lineages, ages and diseases. To consolidate these efforts, we harmonised and integrated scRNAseq datasets across the whole GI tract from developing and adult human tissues, as well as newly generated data from preterm gut. We uniformly processed 385 samples from 189 healthy controls using a newly developed automated QC approach (scAutoQC). In total, our healthy reference contains ~1.1 million cells which we annotated to a total of 137 fine-grained cell states. We anchor 13 published and 1 unpublished GI disease datasets covering gastric and colorectal (CRC) cancers, celiac disease, ulcerative colitis (UC) and Crohn's disease (CD) to this reference, taking our atlas to a total of 1.6 million cells. We provide our atlas as a valuable resource to the community (available at gutcellatlas.org). Using this resource, we discover epithelial cell metaplasia arising from stem cells across intestinal inflammatory diseases (celiac, UC and CD) and CRC with transcriptional similarity to cells of the gastric and Brunner's glands. Whilst previously linked to mucosal healing, we now implicate these cells in inflammation through recruitment of immune cells including T cells and neutrophils, and through direct interactions with T cells. Overall, we discover a shift in paradigm whereby changes in stem cells during inflammation lead to altered mucosal tissue architecture, which in turn contributes to ongoing inflammation. These findings highlight that in addition to barrier function, epithelial cells actively contribute to progression of inflammation which may be a function applicable to other tissues and diseases.

Year:

2024

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Collaborators (16)

Woochang Hwang

-

UNITED KINGDOM
View details

Kourosh Saeb-Parsy

Reader

University of Cambridge

UNITED KINGDOM
View details

Ruoyan Li

Assistant Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Christopher J Stewart

Professor of Human Microbiome Research

Newcastle University

UNITED KINGDOM
View details

Julio Saez-Rodriguez

Head of Research

European Bioinformatics Institute

UNITED KINGDOM
View details

Sarah Teichmann

University of Cambridge

UNITED KINGDOM
View details

Reece McCoy

Research Associate

University of Cambridge

UNITED KINGDOM
View details

Roisin Owens

Professor of Bioelectronics

University of Cambridge

UNITED KINGDOM
View details

Vanessa Monteil

Virologist, Researcher

Karolinska Institutet

SWEDEN
View details

Frode Jahnsen

Professor at University of Oslo

University of Oslo

NORWAY
View details

Sebastian Lobentanzer

Principal Investigator

Helmholtz Zentrum München Deutsches Forschungszentrum für Umwelt und Gesundheit

GERMANY
View details

Namshik Han

IBS Professor

Yonsei University

SOUTH KOREA
View details

paul klenerman

University of Oxford

UNITED KINGDOM
View details

Kylie Renee James

University of New South Wales

AUSTRALIA
View details

Alexander Predeus

Principal bioinformatician

Wellcome Sanger Institute

UNITED KINGDOM
View details

Simon Koplev

Assistant Professor at KTH Royal Institute of Technology

KTH Royal Institute of Technology

SWEDEN
View details